Katie S. Wraith

551 total citations
10 papers, 432 citations indexed

About

Katie S. Wraith is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Hematology. According to data from OpenAlex, Katie S. Wraith has authored 10 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Immunology and 3 papers in Hematology. Recurrent topics in Katie S. Wraith's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Platelet Disorders and Treatments (3 papers). Katie S. Wraith is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Platelet Disorders and Treatments (3 papers). Katie S. Wraith collaborates with scholars based in United Kingdom, Germany and Canada. Katie S. Wraith's co-authors include Khalid M. Naseem, Ahmed Aburima, Simbarashe Magwenzi, Zaher Raslan, Robert Law, Benjamin E. J. Spurgeon, Huw S. Jones, Mark T. Kearney, Martin Berger and Nadira Yuldasheva and has published in prestigious journals such as Blood, Atherosclerosis and Journal of the American Heart Association.

In The Last Decade

Katie S. Wraith

9 papers receiving 428 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Katie S. Wraith 138 135 113 103 86 10 432
Simbarashe Magwenzi 143 1.0× 135 1.0× 105 0.9× 109 1.1× 80 0.9× 6 414
Zaher Raslan 135 1.0× 135 1.0× 107 0.9× 141 1.4× 81 0.9× 13 442
Thomas M. Coffman 140 1.0× 131 1.0× 84 0.7× 84 0.8× 98 1.1× 9 572
Zhiyong Qi 184 1.3× 206 1.5× 124 1.1× 49 0.5× 159 1.8× 27 584
Iwona Żak 133 1.0× 144 1.1× 104 0.9× 106 1.0× 135 1.6× 56 593
Taijyu Satoh 272 2.0× 228 1.7× 64 0.6× 50 0.5× 89 1.0× 37 723
Stefan Seibold 252 1.8× 103 0.8× 113 1.0× 48 0.5× 81 0.9× 17 632
Giovanna Baccante 172 1.2× 116 0.9× 119 1.1× 59 0.6× 95 1.1× 19 546
Ziba Rahimi 114 0.8× 104 0.8× 61 0.5× 85 0.8× 23 0.3× 43 582
T. Royo 122 0.9× 86 0.6× 106 0.9× 92 0.9× 162 1.9× 24 474

Countries citing papers authored by Katie S. Wraith

Since Specialization
Citations

This map shows the geographic impact of Katie S. Wraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katie S. Wraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katie S. Wraith more than expected).

Fields of papers citing papers by Katie S. Wraith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katie S. Wraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katie S. Wraith. The network helps show where Katie S. Wraith may publish in the future.

Co-authorship network of co-authors of Katie S. Wraith

This figure shows the co-authorship network connecting the top 25 collaborators of Katie S. Wraith. A scholar is included among the top collaborators of Katie S. Wraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katie S. Wraith. Katie S. Wraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wraith, Katie S., Ahmed Aburima, Martin Berger, et al.. (2025). The immune receptor FcRγ-chain mediates CD36-induced platelet activation and thrombosis by oxidized low-density lipoproteins. Blood Advances. 9(22). 5774–5786.
2.
Aburima, Ahmed, Martin Berger, Benjamin E. J. Spurgeon, et al.. (2020). Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets. Blood. 137(5). 678–689. 53 indexed citations
3.
Berger, Martin, Zaher Raslan, Ahmed Aburima, et al.. (2019). Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A. Haematologica. 105(3). 808–819. 29 indexed citations
4.
Kahal, Hassan, Ahmed Aburima, Benjamin E. J. Spurgeon, et al.. (2018). Platelet function following induced hypoglycaemia in type 2 diabetes. Diabetes & Metabolism. 44(5). 431–436. 23 indexed citations
5.
Berger, Martin, Katie S. Wraith, Ahmed Aburima, et al.. (2018). Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation. Platelets. 30(4). 467–472. 16 indexed citations
6.
Magwenzi, Simbarashe, Katie S. Wraith, Ahmed Aburima, et al.. (2015). Oxidized LDL activates blood platelets through CD36/NOX2–mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood. 125(17). 2693–2703. 136 indexed citations
7.
Wraith, Katie S., et al.. (2015). Oxidised LDL activates blood platelets through CD36-NADPH oxidase-mediated inhibition of the cgmp/protein kinase g signalling cascade. Atherosclerosis. 241(1). e5–e6. 1 indexed citations
8.
Aye, Myint Myint, Eric S. Kilpatrick, Ahmed Aburima, et al.. (2014). Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome. Journal of the American Heart Association. 3(1). e000706–e000706. 22 indexed citations
10.
Aburima, Ahmed, Katie S. Wraith, Zaher Raslan, et al.. (2013). cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway. Blood. 122(20). 3533–3545. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026